PAA Technologies
From neuroscience platform development to commercial products
PAA Technologies is developing a staged product and commercialisation pathway that progresses from core neuroscience and AI platform development into health and wellness applications, while preserving future opportunities for regulated clinical translation.
The Core Neuroscience Platform
Develop a reusable neuroscience and AI platform capable of supporting multiple commercial products across health, wellness and future regulated domains.
Develop the company's neuroscience and AI-enabled technology platform, creating reusable capabilities for physiological data acquisition, signal analytics, software products, cloud infrastructure and AI-driven insight generation.
Foundation for multiple commercial products.
Core Capabilities:
Research • Data • Analytics • Software • AI
Product & Commercialization Roadmap
Develop a reusable neuroscience and AI platform capable of supporting multiple commercial products across health, wellness and future regulated domains.
Launch the first commercial health and wellness product built upon the platform, translating validated neuroscience and analytical capabilities into a customer-facing commercial offering.
Commercialisation Milestone
First market entry
Extend the platform into fatigue and burnout applications using neuroscience-derived analytical workflows, physiological signal analysis and AI-enabled insight generation.
Platform Expansion
Health & Wellness Applications
As scientific evidence, platform maturity and regulatory readiness develop, selected platform capabilities may provide opportunities for future investigation and translation into regulated clinical applications.
Future Pathway
Evidence → Validation → Regulation → Clinical Translation